NL-OMON55758
Completed
Not Applicable
Towards the development of a personalised E-Health intervention for use in community pharmacies to analyse and improve medication non-adherence in people with type 2 diabetes mellitus, who are non-adherent to oral blood glucose and/or blood pressure lowering drugs. - Improving treatment adherence in people with diabetes mellitus (INTENSE)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Vrije Universiteit Medisch Centrum
- Enrollment
- 150
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- People with type 2 diabetes mellitus that are non\-adherent to oral blood
- •glucose and/or bloodpressure lowering drugs.
- •\- Participants aged 35\-75 years.
- •\- Mobile phone user.
Exclusion Criteria
- •\- People in which adherence data is invalid for instance due to hospital
- •\- People that use medication\-intake supporting pill packaging services provided
- •by the pharmacy.
- •\- People that suffer from major psychiatric disorders.
- •\- People that are \*starters\*, meaning that they started using the medicine
- •somewhere in the period in which the dispensing score was calculated.
- •\- People that are \*stoppers\*, meaning that they did not have a medicine
- •dispatch in the last four months of the period in which the dispensing score
- •was calculated.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Improving treatment adherence in people with diabetes mellitus (INTENSE)Type 2 diabetes mellitus, medication non-adherenceNL-OMON21880Amsterdam UMC, location VUmc300
Completed
Not Applicable
The Effectiveness of a Personalised Digital Health Intervention (Naluri) on Self-Care Behaviours and Quality of Life Outcomes among Cardiac Patients at the Malaysian National Heart Institute: A Randomized Controlled TrialCoronary Heart DiseaseCardiovascular - Coronary heart diseaseACTRN12619000104156aluri Hidup Sdn Bhd200
Completed
Phase 2
Individually tailored E-health interventions for primary care patients with problematic alcohol use and co-occurring depressive symptoms: Phase IIa - proof of concept studyAt-risk alcohol consumption (average daily intake of alcohol > 12g for women / >24gmen or >= one occasion a month with >= 4 alcoholic drinks for women / >= 5 drinks for men).At-risk alcohol consumption is considered as a risk factor for Harmful Alcohol use (ICD-10F10.1), Alcohol Dependence Syndrome (ICD-10 F10.2), and other alcohol attributable disease.subsyndromal depressive symptoms, majordepression (ICD-10 F32) or dysthymia (ICD-10 F34.1)F10.1: Harmful use of alcoholF10.2: Alcohol dependence syndromF10.1F10.2F32F34.1Depressive episodeDysthymiaDRKS00011635niversitätsmedizin Greifswald, Institut für Sozialmedizin und Prävention141
Completed
Phase 1
Individually tailored E-health interventions for primary care patients with problematic alcohol use and co-occurring depressive symptoms (Phase 1)At-risk alcohol consumption (average daily intake of alcohol > 12g for women / >24g men or >= one occasion a month with >= 4 alcoholic drinks for women / >= 5 drinks for men). At-risk alcohol consumption is considered as a risk factor for Harmful Alcohol use (ICD-10 F10.1), Alcohol Dependence Syndrome (ICD-10 F10.2), and other alcohol attributable disease. subsyndromal depressive symptoms, majordepression (ICD-10 F32) or dysthymia (ICD-10 F34.1)F10.1: Harmful use of alcoholF10.2: Alcohol dependence syndromF10.1F10.2F32F34.1Depressive episodeDysthymiaDRKS00007841niversitätsmedizin Greifswald, Institut für Sozialmedizin und Prävention34
Recruiting
Not Applicable
An e-Health system for monitoring patients with Arterial HypertensioHypertension, Cardiovascular diseasesRBR-2rkkgnniversidade de Passo Fundo